One of the primary functions of AMP-activated protein kinase (AMPK) is to regulate the metabolic pathways in response to reduced cellular energy charge. Most of the known targets of the kinase are cytoplasmic enzymes involved in both catabolic and anabolic metabolism. In addition, activation of AMPK in many cells results in changes in the pattern of gene expression. Although some of these effects are undoubtedly secondary responses to modified cellular metabolism, it is possible that in addition to its well-characterized function in the cytoplasm, AMPK also directly phosphorylates and regulates proteins involved in gene transcription. There are now several examples of transcription factors, cofactors and components of the transcriptional core machinery that are directly phosphorylated and regulated by AMPK. Here I review these examples and discuss the significance of AMPK activity in the nucleus.
Introduction
AMP-activated protein kinase (AMPK) is the central component of a cellular signalling system that monitors cellular energy charge, acting as 'metabolic master switch' to regulate ATP concentrations in the face of stresses that reduce cellular energy levels. When activated by high AMP/ATP ratios during states of low energy charge, the kinase acts to reduce the activity of ATP-consuming anabolic pathways and increases the activity of ATP-producing catabolic pathways. Depending on the tissue, a variety of physiological circumstances can cause AMPK activation, including hypoglycaemia [1] , ischaemia [2] , heat shock [3] and exercise [4, 5] . Although much of the work on the effects of AMPK activation has been carried out in skeletal muscle in the context of exercise-induced activation, the kinase clearly plays a key role in metabolic regulation in many other tissues, including heart, adipose tissue, liver and pancreatic islets. For example, AMPK activation results in reduced lipid [6, 7] and glucose synthesis [8, 9] in the liver, and causes changes in glycolytic activity and glucose-stimulated insulin secretion in the endocrine pancreas [1, 10] .
Although many of the known short-term effects of AMPK activation can be explained by direct phosphorylation and regulation of metabolic enzymes in the cytoplasm, long-term activation of the kinase clearly has effects on the pattern of gene expression in a variety of circumstances. In a pancreatic β-cell line, activation of AMPK by a shift to low glucose, or by 5-amino-4-imidazolecarboxamide riboside (AICAR) treatment, causes a reduction in the expression of metabolic genes including GLUT2, aldolase B and liver-type pyruvate kinase (L-PK) [1, 10, 11] . Likewise, in hepatocytes and hepatoma cell lines, activation of AMPK by AICAR causes a decrease in the expression of the fatty acid synthase gene [6] and the genes for phosphoenolpyruvate carboxykinase and glucose-6-phosphatase [12] . The fact that two of these genes encode key enzymes of the gluconeogenic pathway suggests that AMPK-mediated changes in hepatic gene expression could play a role in the regulation of hepatic glucose production. This possibility is supported by the recent observation that the anti-diabetic drug metformin, which suppresses elevated hepatic glucose production [13] , activates AMPK [14] . This observation raises the possibility that at least some of the anti-diabetic effects of metformin are due to AMPK-mediated changes in the expression of metabolic genes.
The observation that AMPK activation induces specific changes in the pattern of gene expression suggests the possibility that AMPK may have direct effects on the activity of nuclear proteins involved in transcriptional regulation. Potential AMPK targets in the nucleus could include specific transcription factors, transcriptional co-activators or co-repressors, or components of the core transcriptional machinery such as RNA polymerase. This possibility is consistent with the known function of the yeast homologue of AMPK, the sucrose non-fermenting 1 (Snf1) complex, which regulates gene expression in response to glucose availability, primarily by phosphorylating transcription factors [15, 16] . Also in support of a potential role for AMPK in the nucleus is the observation that one form of the kinase, containing the α2 subunit, is present in the nucleus [17] .
Although in most cases the mechanism by which AMPK activation causes alterations in the pattern of gene expression is not understood, several examples have now been described in which AMPK modulates the activity of specific transcription regulatory proteins by direct phosphorylation. Here I summarize the few examples of nuclear proteins that have been shown to be direct downstream targets of AMPK.
Phosphorylation of p300 by AMPK inhibits its ability to interact with nuclear receptors
Peroxisome-proliferator-activated receptor γ (PPARγ ) is a ligand-activated transcription factor that plays a key role in the differentiation of fat cells, and functions as the receptor for the anti-diabetic thiazolidinedione drugs [18] . In multiple cellular contexts, PPARγ -mediated transcriptional activity is repressed when AMPK is activated by AICAR treatment ( Figure 1 ). A similar effect was seen with PPARα-and thyroid hormone receptor-mediated transcription but not with transcription mediated by the non-nuclear receptor GATA4 (T. Leff, unpublished work). These observations suggested 20 µM) as indicated. Transfection was carried out as described in [22] .
Data were normalized to a co-transfected β-galactosidase reference plasmid and are the means ± S.D. from three transfections. Veh, vehicle.
Figure 2 AMPK phosphorylation site on p300
The sequence of the p300 and its close relative CBP in the vicinity of the Ser-89 AMPK phosphorylation site (bold) is shown.
that nuclear receptor activity was regulated by AMPK. In considering possible mechanisms for what appeared to be a relatively general regulation of nuclear receptor activity by AMPK, two general possible scenarios emerged : the direct phosphorylation and independent regulation of each nuclear receptor by AMPK, or the phosphorylation and regulation of a cofactor that mediates transcriptional activity of multiple nuclear receptors.
When the amino acid sequences of nuclear receptors and transcriptional cofactor proteins were examined for the presence of consensus AMPK phosphorylation sites, the best match to the AMPK target sequence was a site surrounding Ser-89 in the co-activator p300 (Figure 2 ). p300 and its close relative cAMP response element binding protein (CREB) binding protein (CBP) have been shown to mediate the transcriptional activity of PPARs and other nuclear receptors [19, 20] . The Ser-89 site was particularly interesting as a possible phosphorylation site because of its proximity to an LXXLL motif (Figure 2 ), which is required for the interaction of p300 with nuclear receptors [21] . This suggested the possibility that addition of a phosphate to Ser-89 would influence the ability of the co-activator to interact with nuclear receptors and mediate their transcriptional activity. Indeed, AMPK was shown to phosphorylate p300 on Ser-89, and cause a reduction in its affinity for multiple nuclear receptors [22] . In contrast, phosphorylation at Ser-89 had no effect on the ability of p300 to interact with the non-nuclear receptor transcription factors E1a, p53 or GATA4 [22] .
Although the physiological significance of the phosphorylation of p300 by AMPK is far from understood, these findings strongly support the possibility that at least some of the effects of AMPK activation on PPAR-mediated transcription are due to the phosphorylation of p300 and subsequent inhibition of its ability to interact with nuclear receptors. In addition, these observations suggest that one of the general effects of AMPK activation would be a reduction in the transcriptional activity of the fairly large set of genes that depend on nuclear receptors for at least part of their transcriptional activity.
The nuclear receptor hepatocyte nuclear factor 4 (HNF4) is a downstream target of AMPK
The transcription factor HNF4α regulates the expression of genes involved in energy metabolism in the liver, intestine and endocrine pancreas. The importance of HNF4α in the regulation of metabolism is underscored by the observation that the inheritance of a single null allele of HNF4α causes diabetes in humans [23] . The possibility that HNF4α might be regulated by AMPK was first suggested by the findings of Leclerc et al. [24] who demonstrated that treatment of primary hepatocytes with AICAR caused a dramatic downregulation of the expression of several HNF4 target genes. This was due to a strong reduction in the amount of HNF4 protein, apparently caused by an AMPK-mediated decrease in the stability of the HNF4α protein. These findings suggested the possibility that HNF4α might be a direct target of AMPK and that phosphorylation of the transcription factor would increase its degradation rate.
We examined the possibility that HNF4α was a substrate for AMPK and were able to demonstrate that the kinase phosphorylates HNF4α on Ser-304 in vitro and in cultured cell lines. Ser-304 is located in the ligand binding domain of HNF4α (Figure 3) , a domain that also contains the dimerization function of the protein. In fact, residue 304 is located in an α-helix that appears to participate directly in the formation of homodimers [25] . Substitution of Ser-304 with a phosphomimetic aspartic acid (S304D) caused dramatic reduction in the ability of HNF4α to form homodimers and to bind DNA in a gel-mobility-shift assay (Y.H. Hong, U. Varanasi, W. Yang and T. Leff, unpublished work). Consistent with the findings of Leclerc et al. [24] we found that, in vivo, phosphorylation of HNF4α by AMPK reduced its transcriptional activity, apparently by decreasing the amount of HNF4α protein, again suggesting that the stability of the transcription factor was affected by AMPK (Y.H. Hong, U. Varanasi, W. Yang and T. Leff, unpublished work). Given the key role of HNF4α in regulating metabolism in both the liver and the endocrine pancreas, these findings raise the possibility that an AMPK/HNF4α signalling pathway plays an important role in the physiology of these two important tissues and in the regulation of whole-body energy metabolism. It is also possible that AMPK-mediated regulation of HNF4 activity contributes to the changes in hepatic gene expression that are induced by metformin treatment.
Other nuclear targets of AMPK
Another transcription factor that has been recently identified as a phosphorylation target of AMPK is the carbohydrateresponse-element-binding protein (ChREBP). Like HNF4, ChREBP regulates hepatic genes that encode important metabolic enzymes, including the L-PK gene [27, 28] . It was recently reported that AMPK phosphorylated ChREBP and inhibited its ability to bind DNA [29] . An inhibition of ChREBP transcriptional activity by this mechanism could contribute the down-regulation of L-PK gene expression that has been observed in AICAR-treated hepatocytes [30, 31] and could play a more general role in modulating glucoseresponsive gene expression in the liver.
As described above, the transcriptional activity of many nuclear receptors is inhibited by activation of AMPK via phosphorylation of p300. In the case of PPARα, this effect does not appear to be consistent with one of the primary metabolic functions of the kinase, to increase the activity of ATP-producing pathways in response to depleted cellular ATP levels. PPARα is required for expression of genes involved in fatty acid oxidation [32, 33] , and reduction in its activity would be expected to limit the ability of the cell to restore ATP levels through fatty acid catabolism. A recent report demonstrating that AMPK can function as a transcriptional co-activator of PPARα suggests that the relationship between the kinase and this key metabolic transcription factor may be significantly more complex then originally appreciated [34] . These findings are consistent with the observation that the α2 version of AMPK is found in the nucleus [17] , and raise the possibility that the kinase may also be a functional component of the transcriptional complex, perhaps associated with a specific subset of genes. If so, this could be a potential mechanism for targeting the nuclear effects of AMPK activation to a specific set of genes. In contrast, however, another recent report suggests that, in addition, to these relatively specific effects, AMPK may also have a more global effect on gene expression. AMPK molecules containing the γ 3 subunit were found to be present in nucleoli, the site of rRNA synthesis in the nucleus [35] . Interestingly, it was found that activation of AMPK reduced the activity of RNA polymerase I (Pol I), which carries out the transcription of rRNA [35] . This finding raises the possibility that Pol I in the nucleolus is a target of AMPK and that one of the functions of the kinase in the nucleus is to reduce the general rate of rRNA production. Such a function would be consistent with the general role of the kinase in reducing the rate of energy-utilizing processes.
Concluding remarks
Taken together, the findings described above strongly suggest that in addition to its well-characterized role in regulating the activity of metabolic enzymes in the cytoplasm, AMPK also has important functions in the nucleus, providing a direct link between cellular energy metabolism and the regulation of gene transcription. It is notable that all of the direct nuclear effects of AMPK activation that have been described cause a reduction of transcriptional activity. It may be, in fact, that one of the primary functions of AMPK in the nucleus is to reduce the general rate of transcription, a process that utilizes large amounts of energy. This would certainly be the case for the repression of Pol I activity described above. On the other hand, it appears that AMPK can also carry out a more selective function in the nucleus, modulating the activity of specific transcription factors that regulate the expression of a relatively small set of genes. This mode of AMPK action is exemplified by the phosphorylation of HNF4α and ChREBP as described above. Of course, these are not mutually exclusive scenarios, and it is likely that AMPK has both general and specific effects on gene expression. A great deal of further work needs to be carried out to delineate not only the precise molecular mechanisms by which AMPK regulates gene transcription, but also the role that these regulatory events play in normal and pathological physiology.
